Adrian Gottschalk's Insider Trades & SAST Disclosures
Adrian Gottschalk's most recent trade in Foghorn Therapeutics Inc was a trade of 400,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Adrian Gottschalk.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Aug 2023 | 63,000 | 511,704 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Aug 2023 | 63,000 | 0 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 26 May 2023 | 300,000 | 448,704 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 26 May 2023 | 300,000 | 448,704 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 280,000 | 280,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 16 Sep 2022 | 40,000 | 186,479 | - | 0.5 | 21,600 | Common Stock |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2022 | 40,000 | 418,925 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2022 | 184,939 | 448,704 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2022 | 184,939 | 448,704 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 123,479 | 23,000 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 123,479 | 448,704 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2022 | 4,371 | 67,371 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2022 | 4,371 | 444,333 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 4,371 | 63,000 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 4,371 | 448,704 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 440,000 | 440,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 23,000 | 458,925 | - | - | Stock Options (Right to buy) | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 20 Aug 2021 | 23,000 | 446,479 | - | 0.5 | 12,420 | Common Stock |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, See Remarks | 27 Oct 2020 | 25,225 | 25,225 | - | - | Common Stock | ||
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, See Remarks | 27 Oct 2020 | 18,018 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, See Remarks | 27 Oct 2020 | 7,207 | 0 | - | - | Series B Convertible Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges